At this time, Oxytrol is not available as a generic. The drug is currently protected by a patent that prevents any generic forms from being manufactured in the United States. Although this patent doesn't expire until April 2020, a settlement between a generic manufacturer and the maker of brand-name Oxytrol will allow for a generic version as early as April 2015.
Starting in September 2013, Oxytrol patches will be available without a prescription and will be sold under the name "Oxytrol for Women" to treat women over age 18 with overactive bladder. The prescription version will still be available. It is unclear how this will affect the price and insurance coverage for Oxytrol.
Oxytrol® (oxybutynin patch) is a prescription medication used for relieving overactive bladder symptoms. It belongs to a group of drugs known as anticholinergic medications, and it is the first and only overactive bladder medication in patch form.
Oxytrol is made by Watson Pharmaceuticals, Inc. It is currently under the protection of a patent that prevents any generic Oxytrol from being manufactured in the United States.
When Will Generic Oxytrol Be Available?The first patent for Oxytrol currently expires in April 2020. However, a generic version of Oxytrol is expected to be available starting April 2015, due to a lawsuit and settlement between Watson Pharmaceuticals and Barr Laboratories, Inc. (a generic drug manufacturer).
No -- oxybutynin is the active ingredient in Oxytrol (as well as several other drugs), but is not a generic version of it. What can be confusing is that, oftentimes, the active ingredient of any drug is referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.